Citigroup’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Citigroup’s Portfolio XLV Stock Details XLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$41.7M	Buy	262,700 +150,000	+133%	+$22.3M	0.01%	814
2026 Q1	$16.5M	Sell	112,700 -1,128,300	-91%	-$174M	0.01%	1176
2025 Q4	$192M	Buy	1,241,000 +865,000	+230%	+$130M	0.08%	214
2025 Q3	$52.3M	Sell	376,000 -204,000	-35%	-$27.6M	0.02%	614
2025 Q2	$78.2M	Hold	580,000	–	–	0.04%	420
2025 Q1	$84.7M	Buy	580,000 +77,900	+16%	+$11.3M	0.04%	372
2024 Q4	$69.1M	Buy	502,100 +100,000	+25%	+$14.6M	0.04%	398
2024 Q3	$61.9M	Buy	402,100 +382,100	+1,911%	+$57.9M	0.04%	432
2024 Q2	$2.92M	Sell	20,000 -212,500	-91%	-$30.5M	﹤0.01%	2044
2024 Q1	$34.3M	Sell	232,500 -2,500	-1%	-$359K	0.02%	644
2023 Q4	$32M	Buy	235,000 +135,000	+135%	+$17.6M	0.02%	639
2023 Q3	$12.9M	Buy	100,000 +50,000	+100%	+$6.64M	0.01%	989
2023 Q2	$6.64M	Sell	50,000 -101,400	-67%	-$13.4M	﹤0.01%	1333
2023 Q1	$19.6M	Sell	151,400 -130,000	-46%	-$17M	0.01%	839
2022 Q4	$38.2M	Buy	281,400 +20,000	+8%	+$2.65M	0.03%	492
2022 Q3	$31.7M	Sell	261,400 -422,900	-62%	-$54.5M	0.02%	563
2022 Q2	$87.8M	Buy	684,300 +568,000	+488%	+$74.5M	0.07%	243
2022 Q1	$15.9M	Sell	116,300 -553,700	-83%	-$73.3M	0.01%	1054
2021 Q4	$94.4M	Buy	670,000 +100,000	+18%	+$13.3M	0.05%	336
2021 Q3	$72.6M	Buy	570,000 +420,000	+280%	+$55.5M	0.04%	389
2021 Q2	$18.9M	Buy	150,000 +125,000	+500%	+$15.3M	0.01%	1032
2021 Q1	$2.92M	Sell	25,000 -179,800	-88%	-$20.8M	﹤0.01%	2232
2020 Q4	$23.2M	Sell	204,800 -578,200	-74%	-$63.1M	0.01%	943
2020 Q3	$82.6M	Buy	783,000 +55,400	+8%	+$5.83M	0.05%	288
2020 Q2	$72.8M	Sell	727,600 -681,700	-48%	-$67.3M	0.06%	298
2020 Q1	$125M	Buy	1,409,300 +720,200	+105%	+$70M	0.11%	148
2019 Q4	$70.2M	Sell	689,100 -104,500	-13%	-$10M	0.05%	353
2019 Q3	$71.5M	Buy	793,600 +380,400	+92%	+$34.7M	0.06%	321
2019 Q2	$38.3M	Sell	413,200 -303,800	-42%	-$27.3M	0.03%	562
2019 Q1	$65.8M	Buy	717,000 +281,900	+65%	+$25.4M	0.06%	295
2018 Q4	$37.6M	Buy	435,100 +311,500	+252%	+$28.2M	0.04%	503
2018 Q3	$11.8M	Sell	123,600 -108,700	-47%	-$9.82M	0.01%	1176
2018 Q2	$19.4M	Sell	232,300 -282,300	-55%	-$23.4M	0.02%	828
2018 Q1	$41.8M	Sell	514,600 -175,300	-25%	-$14.9M	0.03%	450
2017 Q4	$57M	Buy	689,900 +29,500	+4%	+$2.43M	0.05%	388
2017 Q3	$54M	Sell	660,400 -1,110,800	-63%	-$89.2M	0.04%	363
2017 Q2	$140M	Buy	1,771,200 +1,299,000	+275%	+$99M	0.13%	109
2017 Q1	$35.1M	Sell	472,200 -186,000	-28%	-$13.6M	0.03%	500
2016 Q4	$45.4M	Sell	658,200 -1,049,200	-61%	-$72.8M	0.04%	410
2016 Q3	$123M	Buy	1,707,400 +1,247,300	+271%	+$91.8M	0.12%	144
2016 Q2	$33M	Buy	460,100 +216,100	+89%	+$15.2M	0.03%	445
2016 Q1	$16.5M	Sell	244,000 -52,600	-18%	-$3.52M	0.02%	700
2015 Q4	$21.4M	Sell	296,600 -34,500	-10%	-$2.44M	0.02%	716
2015 Q3	$21.9M	Buy	331,100 +66,300	+25%	+$4.85M	0.02%	677
2015 Q2	$19.7M	Sell	264,800 -100	-0%	-$7.41K	0.02%	791
2015 Q1	$19.2M	Buy	264,900 +153,000	+137%	+$10.9M	0.02%	798
2014 Q4	$7.65M	Sell	111,900 -373,200	-77%	-$25M	0.01%	1464
2014 Q3	$31M	Buy	485,100 +288,900	+147%	+$18.1M	0.03%	587
2014 Q2	$11.9M	Sell	196,200 -62,500	-24%	-$3.67M	0.01%	1143
2014 Q1	$15.1M	Buy	258,700 +149,800	+138%	+$8.63M	0.02%	890
2013 Q4	$6.04M	Sell	108,900 -457,800	-81%	-$24.5M	0.01%	1627
2013 Q3	$28.7M	Sell	566,700 -35,200	-6%	-$1.77M	0.03%	573
2013 Q2	$28.7M	Buy	+601,900	New	+$28.8M	0.03%	517

Other funds holding XLV

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Citigroup's XLV Position: Q2 2026 in Review

Citigroup increased its State Street Health Care Select Sector SPDR ETF (XLV) stake by 82% in Q2 2026, buying an estimated $74M and bringing the position to 1,105,268 shares worth $175M. The position accounts for 0.06% of the portfolio, ranked #284.

Citigroup first reported a position in XLV in Q2 2013 and has held it in 53 quarters since. The position peaked at $711M in Q2 2021. 1,856 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

Citigroup held 1,105,268 shares of State Street Health Care Select Sector SPDR ETF worth $175M as of Q2 2026.
Citigroup bought 497,663 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $74M.
State Street Health Care Select Sector SPDR ETF made up 0.06% of Citigroup's portfolio in Q2 2026, its #284 holding.
Citigroup first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2013 and has held it in 53 quarters since.
Citigroup's State Street Health Care Select Sector SPDR ETF position peaked at $711M in Q2 2021.
1,856 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.